- 2015-10-30 11:21
- database,DNA,genetic testing,genetics
Genetic testing describes the application of laboratory methods to look at a person’s genes (the inherited DNA instructions). Genetic tests can be used to diagnose a genetic condition; screen for a risk of developing a particular health problems; for the selection of treatments; or to assess responses to treatments.
- 2015-05-19 17:34
- tHIS,Healthcare Event,API China
The 2015 Health Industry Summit (tHIS), an event that is predicted to transform the Chinese healthcare industry sector, opened to huge crowds on May 15, with over 210,000 visitors from 150 countries in attendance.
- 2015-04-13 18:28
Canadian biotech Tekmira Pharmaceuticals ($TKMR) is planning to resume its Phase I study of an investigational treatment for Ebola now that the FDA has waved off some lingering safety concerns. The agency had effectively halted development of TKM-Ebola, an RNAi therapy
- 2015-03-31 17:39
BioMarin stock has rallied up 5% in extended trading on news that Shire is interested in acquiring the company Word on the Street is that Shire plc
- 2015-02-05 15:11
- Novartis,Japan,pharma business
Japan plans to temporarily suspend Novartis' ($NVS) pharma business in that country， according to media reports. The Ministry of Health， Labour and Welfare's order will last about 15 days and will cite repeated violations of failure to report adverse events properly， the Japan Timessays.
- 2014-12-04 15:03
- VC Firms,Biotechs,venture capital
The stampede is back on among venture capital firms to raise new money and close more funds, after years of standing pat following the recession and years of sluggish recovery.Polaris Partners became the latest VC firm in the money
- 2014-11-17 16:25
GlaxoSmithKline ($GSK) has long explored a sale of some $3 billion worth of its older drugs, planning to shed products by geographic region to meet buyers' interests. Now, the company could have a more enticing offer on its hands as private equity firm Apollo Global Management is planning to bid on GSK's entire portfolio of drugs, people familiar with the process toldReuters.
- 2016-01-29 15:40
- Merck,FDA,Clostridium difficile,Bezlotoxumab
Merck announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for bezlotoxumab, an investigational antitoxin for prevention of Clostridium difficile (C. difficile) infection recurrence.
- 2016-01-11 15:16
Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for sarilumab.
- 2015-10-30 17:46
- BMS,HIV particles,HIV drug
A Bristol-Myers Squibb (BMS) drug that causes immature HIV particles to be released from cells early, interrupting their lifecycle, has cleared a proof-of-concept study.
- 2015-10-27 16:38
The CHMP has adopted a positive opinion recommending a change to the terms of the marketing authorisation for Janssen’s Edurant (rilpivirine) in the EU to extend the indication to adolescent patients aged 12 to <18 years with human immunodeficiency virus-1 (HIV-1) infection
- 2015-10-20 15:52
- biotechnology industry,biotech company,clinical trials,Neos Therapeutics,Regulatory
Neos Therapeutics got an ominous note from the FDA just weeks ahead of the expected approval date for its long-acting ADHD treatment, clouding the future of the company's lead asset.
- 2015-02-13 14:50
- SpringFestival,14th February,24th February
Holiday arrangements for Chinese SpringFestival. 14th February to 24th February(11days), 9th February will be adjusted towork.
- 2014-07-01 15:24
- 2014,Shanghai,CPhI & P-MEC China,Exhibition,cphi
Our company successfully exhibitors 2014 Shanghai CPhI & P-MEC China.